Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methlation inhibitor guadecitabine. Homo sapiens
收藏NIAID Data Ecosystem2026-03-09 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA355320
下载链接
链接失效反馈官方服务：
资源简介：
Comparison of gene expression in cisplatin resistant testicular germ cell tumor xenografts treated with vehicle (PBS) or the DNA methylation inhibitor guadecitabine Overall design: Total RNA was isolated from flank xenograft tumors treated once per day for 4 days with 1.5 mg/kg guadecitabine or PBS. Drug was subcutaneous injection. Both control and guadecitabine treatments were in biological triplicates.
创建时间：
2016-11-29
